This French project investigates over 2200 protein to protein interactions whose structures are already known, which play a part in neuromuscular diseases.
Researchers hope to design molecules to inhibit or enhance particular macromolecules, hopefully leading to better treatments for neuromuscular diseases.
Minimum quorum is 2.